Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
Deep sleep is the restorative phase of sleep where the body undergoes essential processes such as tissue repair, muscle growth, and hormone regulation
Anti-inflammatory BPC-157 in particular is studied in animal research for gut-lining and systemic inflammation
Every newborn: progress, priorities, and potential beyond survival [published correction appears in Lancet
US$ 23.23
US$ 29.76
US$ 22.11
US$ 27.56
US$ 20.73
